Skip to main content

Table 9 Late adverse events recorded after concurrent high-dose intensity-modulated radiation therapy and docetaxel-based chemotherapy: gastrointestinal symptoms

From: Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

 

Grade

Diarrhea

Gastritis

Proctitis

Hematochezia

Highest during follow-up

Highest at last follow-up

Cohort 1

1

1

1

1

1

3

1

2

0

0

1

1

1

0

3

0

0

0

0

0

0

Cohort 2

1

1

0

2

2

3

2

2

1

0

1

0

2

0

 

3

0

0

0

0

0

0